Most common Lybalvi side effects, like drowsiness, dry mouth, and headache, improve within the first few weeks of treatment as your body adjusts. Some effects, particularly weight gain and metabolic changes, can persist or develop gradually over months of use. How long any individual side effect lasts depends on which one you’re experiencing, your dose, and how long you’ve been taking the medication.
Lybalvi combines olanzapine (an antipsychotic) with samidorphan (an opioid receptor blocker designed to limit weight gain). Because olanzapine has a long half-life of 35 to 52 hours, the drug stays active in your body for several days after each dose, and side effects tied to its presence in your system can linger even after stopping.
Side Effects That Typically Fade Early
The side effects most likely to improve on their own are the ones your nervous system adapts to over time. Drowsiness is one of the most common early complaints. Olanzapine has strong sedating properties, and many people feel significantly sleepy during the first one to two weeks. As your brain adjusts to the medication, this sedation usually becomes less intense, though some degree of tiredness can persist at higher doses.
Headache, dizziness, and dry mouth also tend to be worst in the first couple of weeks. Dry mouth is a predictable effect of how the drug interacts with certain receptors, and while it often becomes less noticeable, some people experience it for as long as they take Lybalvi. Staying hydrated, chewing sugar-free gum, and using saliva substitutes can help if it lingers. Constipation and indigestion follow a similar pattern: common early on, often manageable with diet adjustments, but sometimes ongoing.
Weight Gain and Metabolic Changes
Weight gain is the side effect most likely to persist and progress over time. In a 12-week clinical trial of patients early in their illness, people taking Lybalvi gained an average of 3.37 kg (about 7.4 pounds), compared to 4.70 kg (about 10.4 pounds) for those on olanzapine alone. The samidorphan component does reduce weight gain compared to olanzapine by itself, but it doesn’t eliminate it. About 33% of Lybalvi patients gained 7% or more of their body weight in 12 weeks, and roughly 22% gained 10% or more.
Weight gain from Lybalvi tends to be most rapid in the first few months, then slows. But it generally does not reverse on its own while you continue taking the medication. Increased appetite is a key driver, reported at rates well above placebo in clinical trials.
Along with weight changes, Lybalvi can raise blood sugar and cholesterol levels. These metabolic shifts may develop gradually over weeks to months and can persist throughout treatment. Your provider will typically monitor blood work periodically to catch these changes early.
Hormonal Effects
Lybalvi raises prolactin levels, a hormone involved in breast development and reproductive function. In a 4-week trial, about 41% of women and 33% of men on Lybalvi developed elevated prolactin. Over a longer 24-week study, the rates were about 33% of women and 23% of men. These numbers are actually somewhat lower than with olanzapine alone, but they’re still significant.
High prolactin can cause missed periods, breast tenderness or discharge, and sexual dysfunction. These effects typically last as long as the medication is taken and resolve after stopping, though it can take several weeks for hormone levels to normalize. Long-term elevated prolactin, if paired with low sex hormone levels, may also affect bone density over time.
How Long Side Effects Last After Stopping
Once you stop taking Lybalvi, the olanzapine component has a half-life of 35 to 52 hours, meaning it takes roughly 8 to 12 days for the drug to clear your system almost entirely. Samidorphan clears much faster, with a half-life of 7 to 11 hours. Side effects directly caused by the drug’s activity in your brain, like sedation and dry mouth, generally fade as the medication leaves your body over that 1 to 2 week window.
Weight gained during treatment does not automatically reverse after stopping. Many people need to actively work on diet and exercise to lose weight accumulated while on the medication. Metabolic changes like elevated blood sugar or cholesterol may start improving within weeks of discontinuation, but the timeline varies.
Prolactin levels typically begin dropping within days of stopping and return to normal within a few weeks for most people.
Rare but Serious Reactions
A small number of people can develop a severe allergic reaction called DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). This typically appears 2 to 6 weeks after starting the medication, not immediately. Symptoms include fever, a spreading rash (often starting on the face and upper body), facial swelling, swollen lymph nodes, and signs of kidney or liver injury. If a medication has been taken for more than three months without these symptoms, it’s unlikely to cause DRESS.
Lybalvi can also cause false positive results on urine drug tests for opioids. This is a known interference from the samidorphan component and lasts as long as you take the drug. If you’re subject to drug screening, let the testing facility know you’re on Lybalvi so they can use a more specific confirmation method.
Opioid Interactions and Timing
Because samidorphan blocks opioid receptors, Lybalvi can trigger sudden opioid withdrawal in anyone who has opioids in their system. This includes prescription painkillers and medications like methadone or buprenorphine. You need to be completely free of short-acting opioids for a period before starting Lybalvi, and longer for long-acting opioids. The samidorphan component clears the body within about 2 to 3 days after stopping Lybalvi, at which point opioid medications can be used again if needed, though your prescriber will determine the exact timing.